Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 1.00 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | DDO | Q99489 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 3/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32681985 | 1.00 | CA2 (1.00) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL28568569 | 0.83 | CA2 (0.71) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL329510 | 0.82 | CA2 (0.69) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL28535223 | 0.81 | CA2 (0.66) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL29560278 | 0.80 | CA2 (0.67) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL5610313 | 0.80 | CA2 (0.67) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL7014167 | 0.80 | CA2 (0.67) | CA2AOC3AKR1B1DAODDO | |
| SCHEMBL516901 | 0.80 | CA2 (0.67) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL517161 | 0.80 | CA2 (0.67) | CA2CA12CA1CA9AOC3 | |
| SCHEMBL30437414 | 0.79 | CA2 (0.66) | CA2CA12CA1CA9AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119497717-A | Linker, conjugate and uses thereof | 启德医药科技（苏州）有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-118251241-A | Antibodies, linkers, supports, conjugates and uses thereof | 启德医药科技（苏州）有限公司 | 2024-06-25 | — | — | CN | claimed |
| WO-2024002330-A1 | IMMOBILIZED ENDOGLYCOSIDASE FUSION PROTEIN AND USE THEREOF | 启德医药科技（苏州）有限公司 | 2024-01-04 | — | — | WO | claimed |
| WO-2023232144-A1 | OLIGOSACCHARIDE LINKER, LINKER-SUPPORTED MATERIAL COMPRISING OLIGOSACCHARIDE LINKER, ANTIBODY-DRUG CONJUGATE HAVING SUGAR CHAIN REMODELING, PREPARATION METHOD THEREFOR AND USE THEREOF | 启德医药科技（苏州）有限公司 | 2023-12-07 | — | — | WO | claimed |
| CN-117177775-A | Linker, conjugate and uses thereof | 启德医药科技（苏州）有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-116940236-A | Composition containing benzylamine acaricide and application thereof | 山东康乔生物科技有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116917484-A | Ligase fusion proteins and uses thereof | 启德医药科技（苏州）有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116874406-A | Indolyl sulfonamide compound and preparation method and application thereof | 山东大学 | 2023-10-13 | — | — | CN | claimed |
| CN-116784339-A | Pesticide composition and application thereof | 山东省联合农药工业有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-114395051-B | Ligase fusion proteins and uses thereof | 启德医药科技（苏州）有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-101434571-A | Cycloalkano [1,2-b] indole sulfonic acid amide, and method for synthesizing isomer or salt thereof | HANGZHOU RONGLI MEDICINE TECHN (CN) | 2009-05-20 | — | — | CN | claimed |
| EP-1947085-A1 | Substituted indole sulfonamide compounds, their preparation and use as medicaments | Laboratorios del Dr. Esteve S.A. (ES) | 2008-07-23 | — | — | EP | claimed |
| US-5374647-A | Anticoagulants, thromboxane synthase inhibitors | BAYER AKTIENGESELLSCHAFT (DE) | 1994-12-20 | — | — | US | claimed |
| US-5204374-A | Anticoagulants; thromboxane A2-antagonist; antiischemic agents; cardiovascular disorders; asthma; antiallergens | BAYER AKTIENGESELLSCHAFT (DE) | 1993-04-20 | — | — | US | claimed |
| CN-1070397-A | Dihydropyridine and method for making and medicinal thereof that the indoles sulphonamide replaces | BAYER AG (DE) | 1993-03-31 | — | — | CN | claimed |
| EP-0533014-A1 | Indolesulfonamide substituted dihydropyridines, process for their preparation and drugs containing them | BAYER AG (DE) | 1993-03-24 | — | — | EP | claimed |
| EP-0473024-A1 | Heterocyclic substituted cycloalkano(b)-indolesulfonamides | BAYER AG (DE) | 1992-03-04 | — | — | EP | claimed |
| CN-1015711-B | Cycloalkaho [1,2-b] indole-sulphonamides | BAYER AG (DE) | 1992-03-04 | — | — | CN | claimed |
| EP-0451634-A2 | Cycloalkano[b]dihydroindoles and -indolesulphonamides substituted by heterocycles | BAYER AG (DE) | 1991-10-16 | — | — | EP | claimed |
| US-4965258-A | Anticoagulant; thromboxane a2 antagonist | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-23 | — | — | US | claimed |